関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | Morpholine | HCID 8083 | — |
| 反応物 | 2-Piperidone | HCID 12665 | — |
| 反応物 | Phosphorus pentachloride | HCID 24819 | — |
| 反応物 | Chlorosuccinimide | HCID 31398 | — |
| 反応物 | (4-Methoxyphenyl)hydrazine | HCID 77023 | — |
| 反応物 | 2-Ketobutyrate | HCID 3593277 | — |
| 溶媒 | Ethyl Acetate | HCID 8857 | — |
| 生成物 | 3-(Morpholin-4-yl)-1,2,5,6-tetrahydropyridin-2-one | HCID 21891460 | — |
反応手順
Condensation of ethylglyoxalate with 4-methoxyphenyl hydrazine and chlorination with NCS afforded (4-Methoxy-phenyl)-chlorohydrazono]-acetic acid ethyl ester. Separately d-valerolactam was dichlorinated with PCl5 and treated with morpholine at reflux to afford 3-Morpholin-4-yl-5,6-dihydro-1H-pyridin-2-one. [3+2] cycloaddition of the chlorohydrazone with the morpholine dihydropyridinone obtained above in refluxing toluene and triethylamine afforded the key intermediate 1-(4-Methoxy-phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester. Alkylation (with 4-bromo-butyrylacetate) followed by deprotection of the acetate group as outlined outlined in Example 32, and amidation of the ester with ammonia afforded the desired compound. Mass Spec 357.3(M−H)−.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 特許番号 | US07135469B2 |
|---|
| 出典データセット | uspto-grants-2006_11 |
|---|
| ORD ID | ord-3eb28c09cb4e42dc9edadb44acdeeb86 |
|---|
| 出典メモ | uspto-grants-2006_11 |
|---|